Lite Strategy, Inc. Impairment of Intangible Assets, Finite-lived
Lite Strategy, Inc. (LITS) reported Impairment of Intangible Assets, Finite-lived of $0 for the 12-month period ending 2022-06-30, per its 10-K filed 2022-09-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2022-09-08
- Lite Strategy, Inc. impairment of intangible assets, finite-lived for the quarter ending 2015-06-30 was $0.00.
- Lite Strategy, Inc. impairment of intangible assets, finite-lived for the quarter ending 2015-03-31 was $0.00.
- Lite Strategy, Inc. impairment of intangible assets, finite-lived for the quarter ending 2014-12-31 was $0.00.
- Lite Strategy, Inc. impairment of intangible assets, finite-lived for the quarter ending 2014-09-30 was $0.00.
- Lite Strategy, Inc. impairment of intangible assets, finite-lived for fiscal 2022 was $0.00.
- Lite Strategy, Inc. impairment of intangible assets, finite-lived for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Lite Strategy, Inc. impairment of intangible assets, finite-lived for fiscal 2020 was $227.00K.
- Lite Strategy, Inc. impairment of intangible assets, finite-lived for fiscal 2019 was $0.00.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|---|---|---|
| 2022-06-30 | $0.00 10-K · filed 2022-09-08 | |||
| 2021-06-30 | $0.00 10-K · filed 2022-09-08 | |||
| 2020-06-30 | $227.00K 10-K · filed 2022-09-08 | |||
| 2019-06-30 | $0.00 10-K · filed 2019-08-28 | |||
| 2018-06-30 | $0.00 10-K · filed 2019-08-28 | |||
| 2017-06-30 | $0.00 10-K · filed 2019-08-28 | |||
| 2016-06-30 | $0.00 10-K · filed 2018-08-30 | |||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-05 | $0.00 derived: sum of 2 quarters · filed 2017-09-05 | $0.00 derived: sum of 3 quarters · filed 2017-09-05 | $0.00 10-K · filed 2017-09-05 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-07 | $0.00 derived: sum of 2 quarters · filed 2015-05-07 | $0.00 10-Q · filed 2015-05-07 | $0.00 derived: sum of 4 quarters · filed 2016-09-06 |
| 2014-12-31 | $0.00 10-Q · filed 2015-02-06 | $0.00 10-Q · filed 2015-02-06 | $0.00 derived: sum of 3 quarters · filed 2016-09-06 | $0.00 derived: sum of 4 quarters · filed 2016-09-06 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-06 | $0.00 derived: sum of 2 quarters · filed 2016-09-06 | $0.00 derived: sum of 3 quarters · filed 2016-09-06 | $0.00 derived: sum of 4 quarters · filed 2016-09-06 |
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-06 | $0.00 derived: sum of 2 quarters · filed 2016-09-06 | $0.00 derived: sum of 3 quarters · filed 2016-09-06 | $0.00 10-K · filed 2016-09-06 |
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-08 | $0.00 derived: sum of 2 quarters · filed 2014-05-08 | $0.00 10-Q · filed 2014-05-08 | $0.00 derived: sum of 4 quarters · filed 2015-09-02 |
| 2013-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-11 | $0.00 10-Q · filed 2014-02-11 | $0.00 derived: sum of 3 quarters · filed 2015-09-02 | $0.00 derived: sum of 4 quarters · filed 2015-09-02 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2015-09-02 | $0.00 derived: sum of 3 quarters · filed 2015-09-02 | $0.00 derived: sum of 4 quarters · filed 2015-09-02 |
| 2013-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-02 | $0.00 derived: sum of 2 quarters · filed 2015-09-02 | $0.00 derived: sum of 3 quarters · filed 2015-09-02 | $0.00 10-K · filed 2015-09-02 |
| 2013-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-05-09 | $0.00 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-12 | $0.00 10-Q · filed 2013-02-12 | ||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |